Skip to main content

India Expands Under-Four Warning to All Chlorpheniramine–Phenylephrine Drug Combinations

Courtroom-sketch editorial illustration of an Indian pharmacist separating unlabelled cough-medicine bottles while explaining child-safety guidance to a mother holding a toddler, rendered in warm ochre and slate-blue pastel strokes.

India's Health Ministry has required every fixed-dose formulation containing chlorpheniramine maleate and phenylephrine hydrochloride to warn that it must not be used in children younger than four. The warning must appear on labels, package inserts and promotional literature. The notification, published in the Gazette on August 21, followed the Drugs Technical Advisory Board's February 16 recommendation.

Sources

Primary sources:1

Something went wrong

We couldn't complete that action. Check your connection and try again.